Past News

The first AI breast cancer sleuth that shows its work

January 14, 2022

Researchers have developed an artificial intelligence platform to analyze potentially cancerous lesions in mammography scans to determine if a patient should receive an invasive biopsy. But unlike its many predecessors, the algorithm is interpretable, meaning it shows physicians exactly how it came to its conclusions.

The first AI breast cancer sleuth that shows its work

Novel treatment target for heart disease found in the blood vessel wall

January 14, 2022

A molecule of RNA called CARMN has been found in abundance in the healthy smooth muscle cells that help give our blood vessels strength and flexibility, and distinctly decreased in vascular diseases like atherosclerosis, a major cause of heart attack and stroke, scientists report.

Novel treatment target for heart disease found in the blood vessel wall

Biostatisticians launch Cancer-Immu data portal for predicting response to immune checkpoint blockade immunotherapy

January 14, 2022

A new data portal called Cancer-Immu established by a team of biostatisticians can help cancer clinicians and researchers predict which patients will respond to immune checkpoint inhibitors. With data from 3,652 samples for 16 cancer types, Cancer-Immu is the largest immune checkpoint blockade-related data portal for exploring immunogenomic connections.

Biostatisticians launch Cancer-Immu data portal for predicting response to immune checkpoint blockade immunotherapy

Identifying New Biomarkers to Detect Lung Cancer Earlier

January 14, 2022

Lung cancer, the leading cause of cancer deaths worldwide killing 1.8 million people each year, is often diagnosed at an advanced stage when the chances for a cure are limited. In the United States, almost 60% of people diagnosed with localized lung and bronchus cancer are likely to survive for 5 years. This is nearly 10 times more than those who are not diagnosed until their cancer has spread to distant parts of the body, who have a 5-year relative survival of 6.3%. Right now, more than half of lung cancers are diagnosed at this late state. Researchers are working to change that with a precision approach to early detection.

Identifying New Biomarkers to Detect Lung Cancer Earlier

First study to detect Delta variant of SARS-CoV-2 in maternal bloodstream and placenta in cases of stillbirth and pregnancy complications

January 13, 2022

Data indicate that pregnant women with COVID-19 had an increased risk for stillbirth when the Delta variant of the SARS-CoV-2 virus was the dominant strain in the United States. Researchers identified the Delta variant in the blood and placentas of several women with COVID-19 who had stillbirths and pregnancy complications.

First study to detect Delta variant of SARS-CoV-2 in maternal bloodstream and placenta in cases of stillbirth and pregnancy complications

Purdue researchers develop cancer immunotherapy treatment

January 13, 2022

Researchers in Purdue University's College of Pharmacy are further developing a potential immunotherapy treatment for cancer, one focused on the mutation of an enzyme.

Purdue researchers develop cancer immunotherapy treatment

Wearable air sampler assesses personal exposure to SARS-CoV-2

January 12, 2022

Researchers have developed a passive air sampler clip that can help assess personal exposure to SARS-CoV-2, which could be especially helpful for workers in high-risk settings, such as restaurants or health care facilities.

Wearable air sampler assesses personal exposure to SARS-CoV-2

Fastest DNA sequencing technique helps undiagnosed patients find answers in mere hours

January 12, 2022

A research effort set the first Guinness World Record for the fastest DNA sequencing technique, which was used to sequence a human genome in just 5 hours and 2 minutes.

Fastest DNA sequencing technique helps undiagnosed patients find answers in mere hours

Face masks cut distance airborne pathogens could travel in half, new study finds

January 12, 2022

The effectiveness of face masks has been a hotly debated topic since the emergence of COVID-19. However, a new study offers more evidence that they work. Researchers found that face masks reduce the distance airborne pathogens could travel, when speaking or coughing, by more than half compared to not wearing a mask.

Face masks cut distance airborne pathogens could travel in half, new study finds

New treatment target ID’d for radiation-resistant cervical cancer

January 12, 2022

Understanding how cells die is key to developing new treatments for many diseases, whether the goal is to make cancer cells die or keep healthy cells alive in the face of other illnesses, such as massive infections or strokes. Two new studies have identified a previously unrecognized pathway of cell death -- named lysoptosis -- and demonstrate how it could lead to new therapies for cervical cancer.

New treatment target ID’d for radiation-resistant cervical cancer